Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1990;47(2):281-328.
doi: 10.1016/0163-7258(90)90091-f.

Hepatic circulation: potential for therapeutic intervention

Affiliations
Review

Hepatic circulation: potential for therapeutic intervention

F Ballet. Pharmacol Ther. 1990.

Abstract

In recent years, knowledge of the physiology and pharmacology of hepatic circulation has grown rapidly. Liver microcirculation has a unique design that allows very efficient exchange processes between plasma and liver cells, even when severe constraints are imposed upon the system, i.e. in stressful situations. Furthermore, it has been recognized recently that sinusoids and their associated cells can no longer be considered only as passive structures ensuring the dispersion of molecules in the liver, but represent a very sophisticated network that protects and regulates parenchymal cells through a variety of mediators. Finally, vascular abnormalities are a prominent feature of a number of liver pathological processes, including cirrhosis and liver cell necrosis whether induced by alcohol, ischemia, endotoxins, virus or chemicals. Although it is not clear whether vascular lesions can be the primary events that lead to hepatocyte injury, the main interest of these findings is that liver microcirculation could represent a potential target for drug action in these conditions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Abecassis M., Falk J.A., Makowka L., Dindzans V.J., Falk R.E., Levy G.Z. 16,16 dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J. clin. Invest. 1987;80:881–889. - PMC - PubMed
    1. Ahmad A.B., Bennett P.N., Rowland M. Influence of route of hepatic administration on drug availability. J. Pharmac. exp. Ther. 1984;230:718–725. - PubMed
    1. Akerboom T., Lenzen R., Schneider I., Sies H. Cholestasis and changes in the microcirculation of perfused rat liver caused by the calcium ionophore A 23187 and type I antiarrhythmic drugs. Biochem. Pharmac. 1987;36:3037–3042. - PubMed
    1. Altin J.G., Bygrave F.L. Prostaglandin F2α and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Biochem. J. 1988;249:677–685. - PMC - PubMed
    1. Altin J.G., Bygrave F.L. Non-parenchymal cells as mediators of physiological responses in liver. Molec. cell. Biochem. 1988;83:3–4. - PubMed

Publication types